253 related articles for article (PubMed ID: 12431394)
1. Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1.
Svenson M; Jacobi HH; Bødtger U; Poulsen LK; Rieneck K; Bendtzen K
Mol Immunol; 2003 Jan; 39(10):603-12. PubMed ID: 12431394
[TBL] [Abstract][Full Text] [Related]
2. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
3. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation.
van Neerven RJ; Wikborg T; Lund G; Jacobsen B; Brinch-Nielsen A; Arnved J; Ipsen H
J Immunol; 1999 Sep; 163(5):2944-52. PubMed ID: 10453043
[TBL] [Abstract][Full Text] [Related]
4.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
5. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
6. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization.
Movérare R; Westritschnig K; Svensson M; Hayek B; Bende M; Pauli G; Sorva R; Haahtela T; Valenta R; Elfman L
Int Arch Allergy Immunol; 2002 Aug; 128(4):325-35. PubMed ID: 12218371
[TBL] [Abstract][Full Text] [Related]
7. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation.
van Neerven RJ; Arvidsson M; Ipsen H; Sparholt SH; Rak S; Würtzen PA
Clin Exp Allergy; 2004 Mar; 34(3):420-8. PubMed ID: 15005736
[TBL] [Abstract][Full Text] [Related]
9. Quality and potency profile of eight recombinant isoallergens, largely mimicking total Bet v 1-specific IgE binding of birch pollen.
Seutter von Loetzen C; Reuter A; Spiric J; Schulenborg T; Bellinghausen I; Völker E; Vogel L; Rösch P; Schiller D
Clin Exp Allergy; 2019 May; 49(5):712-723. PubMed ID: 30706562
[TBL] [Abstract][Full Text] [Related]
10. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4.
Shirasaki H; Yamamoto T; Koyanagi Y; Watanabe N; Himi T
Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509
[TBL] [Abstract][Full Text] [Related]
11. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China.
Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD
J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268
[TBL] [Abstract][Full Text] [Related]
12. IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in mice.
Ganglberger E; Grünberger K; Wiedermann U; Vermes M; Sponer B; Breiteneder H; Scheiner O; Boltz G; Jensen-Jarolim E
Int Arch Allergy Immunol; 2001; 124(1-3):395-7. PubMed ID: 11307026
[TBL] [Abstract][Full Text] [Related]
13. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal IgE antibodies against birch pollen allergens: novel tools for biological characterization and standardization of allergens.
Kaul S; Scheurer S; Danz N; Schicktanz S; Vieths S; Hoffmann A
J Allergy Clin Immunol; 2003 Jun; 111(6):1262-8. PubMed ID: 12789227
[TBL] [Abstract][Full Text] [Related]
15. Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin).
Ebner C; Hirschwehr R; Bauer L; Breiteneder H; Valenta R; Ebner H; Kraft D; Scheiner O
J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):962-9. PubMed ID: 7751517
[TBL] [Abstract][Full Text] [Related]
16. Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles.
Rossi RE; Monasterolo G; Monasterolo S
Allergy; 2003 Sep; 58(9):929-32. PubMed ID: 12911423
[TBL] [Abstract][Full Text] [Related]
17. Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes.
Brazhnikov G; Smolnikov E; Litovkina A; Jiang T; Shatilov A; Tulaeva I; Tulaev M; Karaulov A; Poroshina A; Zhernov Y; Focke-Tejkl M; Weber M; Akinfenwa O; Elisyutina O; Andreev S; Shilovskiy I; Shershakova N; Smirnov V; Fedenko E; Lepeshkova TS; Beltyukov EC; Naumova VV; Kundi M; Khaitov M; Wiedermann U; Valenta R; Campana R
Allergy; 2023 Dec; 78(12):3136-3153. PubMed ID: 37701941
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins.
Karamloo F; Schmitz N; Scheurer S; Foetisch K; Hoffmann A; Haustein D; Vieths S
J Allergy Clin Immunol; 1999 Nov; 104(5):991-9. PubMed ID: 10550744
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CD23-dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules.
Pree I; Shamji MH; Kimber I; Valenta R; Durham SR; Niederberger V
Clin Exp Allergy; 2010 Sep; 40(9):1346-52. PubMed ID: 20604801
[TBL] [Abstract][Full Text] [Related]
20. Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.
Hofmann C; Scheurer S; Rost K; Graulich E; Jamin A; Foetisch K; Saloga J; Vieths S; Steinbrink K; Adler HS
J Allergy Clin Immunol; 2013 May; 131(5):1384-92.e6. PubMed ID: 23246018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
